Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Shuli Qu
Abiraterone Acetate and Docetaxel With Androgen Deprivation Therapy in High-Volume Metastatic Hormone-Sensitive Prostate Cancer in China: An Indirect Treatment Comparison and Cost Analysis
Cost Effectiveness and Resource Allocation
Health Policy
Comparative Clinical Effects and Cost–effectiveness of Maximum Androgen Blockade, Docetaxel With Androgen Deprivation Therapy and ADT Alone for the Treatment of mHSPC in China
Journal of Comparative Effectiveness Research
Health Policy
Related publications
Cost-Effectiveness Analysis of Abiraterone, Docetaxel or Placebo Plus Androgen Deprivation Therapy for Hormone-Sensitive Advanced Prostate Cancer
Einstein (São Paulo, Brazil)
Medicine
Medical Resource Utilization of Abiraterone Acetate Plus Prednisone Added to Androgen Deprivation Therapy in Metastatic Castration-Naive Prostate Cancer: Results From LATITUDE
Cancer
Cancer Research
Oncology
Abiraterone Acetate for Metastatic Prostate Cancer in Patients With Suboptimal Biochemical Response to Hormone Induction
JAMA Oncology
Cancer Research
Oncology
Chemohormonal Therapy for Metastatic Hormone-Sensitive Prostate Cancer: An Asian Perspective
Asia-Pacific Journal of Clinical Oncology
Medicine
Oncology
‘Charting a New Course for Prostate Cancer’ – Currying Favor for Docetaxel in Hormone-Sensitive Metastatic Prostate Cancer
Expert Review of Anticancer Therapy
Oncology
Pharmacology
Androgen Deprivation Therapy for Prostate Cancer
Mp22-09 Association Between Androgen-Deprivation Therapy and Non-Prostate Cancer Mortality Among Men With Non-Metastatic Prostate Cancer
Journal of Urology
Urology
Sequencing of Sipuleucel-T and Androgen Deprivation Therapy in Men With Hormone-Sensitive Biochemically Recurrent Prostate Cancer: A Phase II Randomized Trial
Clinical Cancer Research
Cancer Research
Oncology
